Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
John L. Magnani
GlycoMimetics Inc
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
91
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
E-Selectin Inhibition Overcomes Endothelial Niche-Mediated Resistance to Bcl-2–Targeted Therapy in AML
Number of pages: 27
Posted: 20 Oct 2022
Kyung Hee Chang
,
Weiguo Zhang
,
Muharrem Muftuoglu
,
Mahesh Basyal
,
Lauren Ostermann
,
Po Yee Mak
,
Yannan Jia
,
Wenjing Tao
,
William E. Fogler
, John L. Magnani,
Bing Z. Carter
and
Michael Andreeff
University of Texas at Houston - Section of Molecular Hematology and Therapy, University of Texas at Houston - Section of Molecular Hematology and Therapy, University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas at Houston - Section of Molecular Hematology and Therapy, University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas at Houston - Section of Molecular Hematology and Therapy, University of Texas at Houston - Section of Molecular Hematology and Therapy, University of Texas at Houston - Section of Molecular Hematology and Therapy, GlycoMimetics Inc, GlycoMimetics Inc, University of Texas at Houston - Section of Molecular Hematology and Therapy and University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia
Downloads
91
(736,406)
View PDF
Download
Abstract:
acute myeloid leukemia, leukemia stem cells, E-selectin, Bcl-2, antagonist
Feedback